| Patient | Dorothea Lange |
|---|---|
| Date of birth | 1964-05-26 |
| Identifiers | MRN HR-ML045-SYN; SSN (made up) 000-45-9127 |
| Document date | 2026-02-25 |
| Author | Gwendolyn Ashford-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Results of the nerve and muscle tests; neuromuscular consultation this morning. [S]
Ms. Lange returns 16 days after presenting with about 18 months of new fatigue, slowly increasing weakness of the left leg and both shoulders as well as her polio-affected right leg, aching after field work, and two falls. Her blood tests at the first visit excluded the common other causes: hemoglobin 13.1, TSH 2.1, HbA1c 5.4 percent, B12 512, creatinine 0.7, ESR 12, and CRP 0.3 were normal; creatine kinase was mildly raised at 228 and 25-hydroxyvitamin D low at 22. Her PHQ-9 was 6. Nerve conduction studies a week ago were normal, and the needle EMG showed chronic reinnervation in the right leg and, more mildly, in the left thigh and right shoulder, with no myopathy. She saw Dr. Haddad-Sorensen this morning, who confirmed post-polio syndrome. Today she had a bone density scan and spirometry. Her heartburn is much better after two weeks of omeprazole. She asked plainly whether this would keep getting worse and whether she would have to stop working in the field. [S]
| Element | Detail |
|---|---|
| Interval change | Nerve conduction normal; EMG chronic reinnervation in three limbs; no myopathy or neuropathy |
| Exclusion tests | Thyroid, blood count, glucose, B12, kidney and liver tests, ESR and CRP normal; creatine kinase mildly raised; vitamin D low |
| Diagnosis | Post-polio syndrome confirmed at the neuromuscular consultation this morning |
| Today | Bone density scan with vertebral fracture assessment; spirometry |
| Heartburn | Better after two weeks of omeprazole |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue after two hours of activity; no fever or weight loss |
| Musculoskeletal | Positive | Aching in both thighs and shoulders after work; no joint swelling |
| Neurological | Positive | Weaker left leg and shoulders; cold right foot; no numbness |
| Respiratory | Negative | No breathlessness lying flat and no morning headache |
| Ears, nose, mouth, and throat | Negative | No trouble swallowing or choking |
| Gastrointestinal | Positive | Heartburn now once or twice a week; no difficulty swallowing, vomiting, or black stools |
| Psychiatric | Positive | Discouraged by the tiredness; no thoughts of self-harm |
7 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 2025-06-02 | active | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth 30 to 60 minutes before breakfast, an eight-week trial for heartburn | One capsule once daily before breakfast | Oral route | 2026-02-09 to 2026-04-06 | completed | S |
| Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once daily | Two tablets once daily | Oral route | 2026-02-25 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-25 | Body height | 152 | cm | S |
| 2026-02-25 | Body weight | 50.3 | kg | S |
| 2026-02-25 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 2026-02-25 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-02-25 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-02-25 | Heart rate | 74 | /min | S |
| 2026-02-25 | Respiratory rate | 14 | /min | S |
| 2026-02-25 | Body temperature | 36.5 | Cel | S |
| 2026-02-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-25 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 58 | pg/mL | 15-65 pg/mL | Normal | S |
| 2026-02-25 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 82 | U/L | 44-147 U/L | Normal | S |
| 2026-02-25 | Phosphate [Mass/volume] in Serum or Plasma | 3.4 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-02-25 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.4 mg/dL | Normal | S |
| 2026-02-25 | Forced vital capacity [Volume] Respiratory system | 2.52 | L | >=2.2 L | Normal | S |
| 2026-02-25 | FVC measured/predicted | 92 | % | 80% of predicted or more is normal | Normal | S |
| 2026-02-25 | FEV1/FVC | 78 | % | >=70% | Normal | S |
| 2026-02-25 | DXA Lumbar spine [T-score] Bone density | -1.8 | {T-score} | -2.5 or lower is osteoporosis | Low | S |
| 2026-02-25 | DXA Femur - right [T-score] Bone density | -2.7 | {T-score} | -2.5 or lower is osteoporosis | Low | S |
| 2026-02-25 | DXA Femur - left [T-score] Bone density | -1.6 | {T-score} | -2.5 or lower is osteoporosis | Low | S |
Vital signs recorded on 2026-02-25; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Small, alert woman; precise historian |
| Musculoskeletal | Right calf and thigh thinner than the left; high-arched right foot; right knee hyperextends in stance |
| Neurological | Strength (MRC): right hip abductors 4-/5, right quadriceps 3+/5, right ankle dorsiflexion 2/5, right plantar flexion 3/5; left quadriceps 4/5, left hip abductors 4/5; deltoids 4+/5 on both sides; reflexes absent at the right knee and ankle, present on the left; sensation normal; no fasciculations |
| Gait | Right foot drop with a steppage gait and right knee hyperextension; Timed Up and Go 14 seconds without an aid |
| Respiratory | Clear; full chest expansion; normal cough |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| New fatigue and slowly increasing weakness for about 18 months, in the left leg and both arms as well as the right leg weakened by polio at seven, with aching muscle pain after work and cold intolerance of the right leg; cause to be established | resolved | confirmed | M62.81 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis of post-polio syndrome at the second visit; the paralytic polio of 1902 is documented (D). |
| Post-polio syndrome (modified March of Dimes criteria met): new weakness of the left quadriceps and both shoulder girdles and increased weakness of the right leg, with fatigue, muscle pain, and cold intolerance, more than 50 years after paralytic polio with partial recovery and decades of stable function; nerve conduction normal; EMG chronic reinnervation in both legs and the right deltoid; other causes excluded | active | confirmed | G14 | S — Synthetic modern diagnosis; the childhood polio is documented (D), and her biographer's account of post-polio symptoms later in life is a retrospective interpretation (R). No neurological finding from her lifetime is used. |
| Heartburn and regurgitation after meals and at night for three months, three to four times a week; no difficulty swallowing, weight loss, vomiting, bleeding, or anemia | active | confirmed | R12 | S — Synthetic presenting symptom at the index visit, superseded by the endoscopic diagnosis at the fourth visit. |
| Osteoporosis, worst at the right hip on the polio-weakened side (right femoral neck T-score -2.7; left -1.6; lumbar spine -1.8), with vitamin D insufficiency; no vertebral fracture on assessment; 10-year FRAX risk about 16 percent major osteoporotic and 4.5 percent hip | active | confirmed | M81.8 | S — Synthetic bone density result; disuse of a polio-affected limb lowers bone density on that side. |
| Two falls in the past year without injury, from catching the right foot | active | confirmed | Z91.81 | S — Synthetic fall history at presentation. |
| Surgery for severe stomach ulcers in her early fifties; no ulcer symptoms since; avoids nonsteroidal anti-inflammatory drugs | active | confirmed | Z87.11 | S — Synthetic modern history entry linked to the documented ulcers and surgery of the late 1940s (D); the type of operation is not known. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Diagnostic criteria for post-polio syndrome | At diagnosis | Completed today | Modified March of Dimes criteria met: prior paralytic polio, partial recovery, stability for decades, new weakness and fatigue for more than a year, other causes excluded |
| Examination | Nerve conduction studies and needle EMG | At diagnosis | Up to date | A week ago: normal nerve conduction; chronic reinnervation in three limbs; no myopathy |
| Laboratory | Exclusion of other causes (thyroid, anemia, glucose, B12, kidney and liver, inflammation, creatine kinase) | At diagnosis | Up to date | At the first visit: all normal except creatine kinase 228 and vitamin D 22 |
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Baseline strength recorded; TUG 14 seconds without an aid |
| Imaging | Spirometry | Baseline, then yearly or with symptoms | Completed today | FVC 2.52 L, 92 percent of predicted; FEV1/FVC 78 percent; normal |
| Examination | Sleep-disordered breathing screen | At diagnosis and with symptoms | Ordered | Unrefreshing sleep; home overnight oximetry booked |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing or choking |
| Referral | Supervised non-fatiguing exercise (physical therapy) | At diagnosis | Ordered | Twelve weeks, starting next week |
| Referral | Orthotic assessment | At diagnosis and when gait changes | Ordered | Custom carbon-fiber right ankle-foot orthosis; cane supplied today |
| Self-management | Energy conservation and pacing | Every visit | Completed today | Field-day plan agreed with rest breaks and a rest day after each field day |
| Medication safety | Sedation and anesthesia precautions | At diagnosis, then before any procedure | Completed today | Alert added to the chart |
| Survey | Depression screen (PHQ-9) | At diagnosis, then periodically | Up to date | PHQ-9 6 at the first visit, mild; supportive care |
| Imaging | Bone density (DXA) with vertebral fracture assessment | Baseline, then every 2 years on treatment | Completed today | Right femoral neck -2.7, left -1.6, spine -1.8; no vertebral fracture |
| Laboratory | Secondary causes of osteoporosis (calcium, vitamin D, PTH, alkaline phosphatase, phosphate, magnesium, creatinine, TSH, blood count) | At diagnosis | Completed today | PTH 58, alkaline phosphatase 82, phosphate 3.4, magnesium 2.0 today; calcium, creatinine, TSH, and blood count normal at the first visit; vitamin D 22 |
| Laboratory | 24-hour urine calcium | At diagnosis | Ordered | Collection kit given, to be returned before the infusion |
| Examination | Fall-risk assessment | At diagnosis, then yearly | Completed today | Two falls; foot drop and quadriceps weakness; TUG 14 seconds |
| Medication safety | Reflux: alarm features and response to the proton pump inhibitor trial | During the 8-week trial | Completed today | Responding; no difficulty swallowing, weight loss, bleeding, or anemia |
Goal progress:
Guideline basis: EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006); Post-Polio Syndrome: Identifying Best Practices in Diagnosis & Care (diagnostic criteria for post-polio syndrome) (2001); American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update. Endocr Pract 2020;26(Suppl 1):1-46 (2020); World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing 2022;51(9):afac205 (2022); CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026)
Follow-up: Physical therapy from next week; orthosis fitting in four weeks; overnight oximetry in two weeks. Primary care review in eight weeks with vitamin D, calcium, and creatinine before zoledronic acid. Next scheduled visit 2026-04-20: review after eight weeks of pacing and physical therapy; first zoledronic acid infusion; planning endoscopy after heartburn returned off omeprazole. [S]